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Any physician involved in primary care will 
encounter patients with menstrual dysfunction. 
Mismanagement of this disorder is not usually 
the result of its complexity but rather the lack of 
an orderly approach. In unusual circumstances 
one may encounter a patient with a menstrual 
disorder of sufficient complexity to require refer­
ral. This decision should be based on a work-up 
indicating such a need rather than frustration af­
ter unsuccessful empiric therapeutic trials. 
The age of the patient is an important con­
sideration for evaluation; the three main cate­
gories are the adolescent, reproductive, and cli­
macteric age groups. 
Adolescent menstrual disorders are gen­
erally the concerns of ''too early,'' ''too late'· or 
"too much." Menarche, or the first period, is 
expected to occur by age 13. "Too early" 
would be prior to age 9 and "too late" would be 
after 16.5 years of age. Those who have men­
arche "too early" usually prove to be individ­
uals who have undergone the normal sequential 
events of puberty and have cyclic hypothalamic 
and ovarian function. Only one out of ten of 
these individuals will have any serious disorder 
such as brain tumor, residual damage after 
meningitis, or Albright disease. If menstruation 
has occurred but cyclic function is absent and 
ovulation does not take place, then a search for 
a source of estrogen must be made, the two 
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most common sources being exogenous estro­
gen that has been ingested or endogenous es­
trogen from a theca-granulosa cell tumor of the 
ovary. 
Therefore, the first effort is to determine if 
the patient's condition reflects a full, orderly, 
pubertal change or whether it represents only 
the effect of estrogenic stimulation. If it appears 
to be true puberty, an intracranial lesion must 
then be ruled out. If it appears to be pseudo­
precocious puberty from estrogen stimulation 
with only menstrual bleeding, skeletal growth 
and breast stimulation, then a source from the 
environment or the ovaries must be sought. 
About 95% of women will have had their 
first menses by age 16.5 years and 99% by 
age 18. A detailed history and thorough phys­
ical examination will give a number of diagnos­
tic clues to a physician confronted with a patient 
who has not yet menstruated. Although it can­
not be precisely predicted, there is a relatively 
orderly sequence of events that occurs with pu­
berty. The gradual elevation of estrogens is re­
flected in the early development of the breasts, 
and about one year later, the rapid increase in 
the rate of skeletal growth. The adrenal 
changes resulting in higher levels of circulating 
androgens influence the growth of axillary and 
public hair. The onset of the first period can be 
expected within about 1 8 months of the rapid 
growth spurt. Therefore, the history and phys­
ical examination will give an indication at about 
what level the problem exists. These patients 
may present in a number of ways. 
First, let us take a 17-year-old female who 
has not menstruated and who has no secondary 
sexual characteristics. We know immediately 
that there are no significant amounts of estro-
gen being made in that individual and must de­
termine whether the gonads are at fault or if the 
disorder is central. A determination of follicle­
stimulating hormone (FSH) and luteinizing hor­
mone (LH) from plasma will divide these pa­
tients into two groups. If the gonadotropins are 
elevated, we know that we are dealing with pri­
mary gonadal failure and must obtain genetic 
studies by karyotyping. The usual abnormal kar­
yotypes found are 45X, 46 abnormal X, 46XX, 
and mosaics. If the gonadotropins are low, we 
are dealing with a central defect. The availability 
of gonadotropin-releasing hormone will allow 
the identification of those who have a hypotha­
lamic dysfunction from those with an anterior pi­
tuitary dysfunction but this hormone is not now 
generally available. At present, the method of 
management for all of these cases will be estro­
gen/ progestin substitution therapy. 
Second, we consider a 17-year-old with 
primary amenorrhea who by history had breast 
development beginning at age 11 , a growth 
spurt evident by age 1 2, and normal axillary 
and pubic hair. We would know that her gonads 
had been producing sex steroids for several 
years and that the hypothalamus and pituitary 
must be functioning. Physical examination 
would be expected to reveal some abnormality. 
An obstruction to the menstrual flow such as im­
perforate hymen might lead to a direct and 
simple solution to the problem. Absence of the 
uterus or vagina (or some combination thereof) 
requires further evaluation. At this point some 
physicians use a buccal smear, others a testos­
terone determination, in order to identify the pa­
tients with testicular feminization syndrome. If 
the findings are positive for this diagnosis, then 
gonadal removal is indicated after completion of 
pubertal changes because of the risk of malig­
nancy Gender identity for this person has al­
ways been female and this should not be dis­
rupted by informing the patient about the details 
of the condition. If a normal testosterone level or 
positive buccal smear is indicative of a genetic 
female, then surgical vaginoplasty may be nec­
essary, but gonadal removal is not necessary 
since a Y chromosome is absent. 
Third, we may be faced with a 17-year-old 
female with a nt,, mal history of puberty, normal 
secondary sexual characteristics, and both va-
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gina and uterus present. The evaluation of this 
individual would be the same as for the woman 
who has previously had menstrual function but 
who now has secondary amenorrhea. First, 
pregnancy should be ruled out. This may be 
done by a progestin or progesterone withdrawal 
test or by a beta human chorionic gonadotropin 
(BHCG) pregnancy test. The latter is probably 
now preferred because of the alleged terato­
genic effect of hormones when pregnancy does 
exist. Once pregnancy is ruled out, a progestin 
or progesterone withdrawal test may be per­
formed to evaluate the level of circulating estro­
gen, although the status of the endometrium 
and patency of the cervix would also influence 
the outcome. Eventually, however, in these pa­
tients a determination of FSH, LH and estradiol 
will be necessary to categorize the patient as in­
dicated in the flow sheet (Figure 1) 
The adolescent with "too much" bleed­
ing, who is otherwise normal, is most likely ex­
periencing anovulatory cycles. The diethylstil­
bestrol (DES) problem has made it important 
that visualization of the vagina and cervix be 
carried out. However, it is not necessary to 
biopsy or curette the endometrium of these indi­
viduals except under unusual circumstances. 
Management is usually by the administration of 
oral contraceptives to control the cycles, and 
oral iron to replenish its loss. 
During the reproductive age a variety of 
menstrual disorders may be found also. For 
those women whose menstrual function has 
ceased (secondary amenorrhea) we can follow 
the course of evaluation previously outlined for 
the anatomically and genetically normal adoles­
cent. For all other disturbances of the cycles, 
where bleeding is not of sufficient magnitude as 
to create an urgent problem, it is necessary to 
rule out pregnancy and to determine whether or 
not ovulation is occurring. If the patient has ex­
cessive menstrual flow or intermenstrual bleed-
ing with good evidence of ovulation (by basal 
body temperature, progesterone assay or endo­
metrial biopsy) then coagulation disorders 
should be ruled out and dilatation and curettage 
performed. If anovulation is demonstrated, en­
dometrial sampling is prudent for those women 
at the end of the reproductive scale to rule out 
abnormal hyperplasia or the rare carcinoma. In 
general, however, these patients can be treated 
by either combined oral contraceptives in a cy­
clic manner or by one week of oral progestin 
each month. When anovulation occurs it is im­
portant to recognize that there is a wide variety 
of emotional, endocrine and general health dis­
turbances that may interfere with the menstrual 
cycle Therefore, evaluation of the patient must 
be general and thorough in order that symp­
toms and signs of other disorders may be 
found. 
Menstrual change in the climacteric is ex­
pected as anovulation becomes more frequent 
and ovarian function progressively declines. 
However, some patients will experience exces­
sive bleeding and/or unpredictable frequent 
episodes of bleeding. The possibility of preg­
nancy still exists in this age group and must be 
considered. However, the most important re­
quirement for these women is the sampling of 
the endometrium. Subsequent management de­
pends upon the pathologist's findings and is 
outlined in Figure 2. 
In summary, control of menstrual function 
is a very complex system that is highly in­
tegrated and subject to a number of types of 
malfunction from both within and without. Identi­
fication of the majority of menstrual disorders is 
within the reach of physicians responsible for 
primary care but requires a thoughtful, orga­
nized approach. Inability to reach a satisfactory 
diagnosis or lack of response by the patient to 
established methods of therapy indicate the 
need for more intensive evaluation. 
